NCT04176835View on ClinicalTrials.gov

Oxytocin and Social Decision Making in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Schizophrenia
Interventions
DRUG

Oxytocin nasal spray

Single-dose oxytocin will be administered intranasally

DRUG

Placebo

All Listed Sponsors
lead

National Institute of Mental Health and Neuro Sciences, India

OTHER

NCT04176835 - Oxytocin and Social Decision Making in Schizophrenia | Biotech Hunter | Biotech Hunter